Tumour-initiating capacity is independent of epithelial-mesenchymal transition status in breast cancer cell lines

British Journal of Cancer

Volumn 110, Issue 10, 2014, Pages 2514-2523

  Xie, G ^a   Ji, A ^b   Yuan, Q ^c   Jin, Z ^d   Yuan, Y ^a   Ren, C ^a   Guo, Z ^a   Yao, Q ^a   Yang, K ^a   Lin, X ^a   Chen, L ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

^c JULES STEIN EYE INSTITUTE   (United States)

^d Jining First People's Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD24 ANTIGEN; CYTOKINE; DOXORUBICIN; HERMES ANTIGEN; MICRORNA 200C;

ARTICLE; BREAST CANCER CELL LINE; CELL FUNCTION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN CELL; MESENCHYME CELL; PHENOTYPE; PRIORITY JOURNAL; RADIATION;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTIGENS, CD44; ANTIGENS, NEOPLASM; BREAST NEOPLASMS; CELL DIVISION; CELL LINE, TUMOR; CELL MOVEMENT; CHOLERA TOXIN; CYTOKINES; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; HYDROCORTISONE; IMMUNOPHENOTYPING; INSULIN; MICE; MICE, INBRED NOD; MICE, SCID; MICRORNAS; NEOPLASM TRANSPLANTATION; NEOPLASTIC STEM CELLS; RADIATION TOLERANCE;

EID: 84900529608     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2014.153     Document Type: Article

References (58)

1. Ackland ML, Newgreen DF, Fridman M, Waltham MC, Arvanitis A, Minichiello J, Price JT, Thompson EW (2003) Epidermal growth factor-induced epithelio-mesenchymal transition in human breast carcinoma cells. La b Invest 83: 435-448.
2. Acloque H, Adams MS, Fishwick K, Bronner-Fraser M, Nieto MA (2009) Epithelial-mesenchymal transitions: The importance of changing cell state in development and disease. J Clin Invest 119: 1438-1449.
3. Ailles LE, Weissman IL (2007) Cancer stem cells in solid tumors. Curr Opin Biotechnol 18: 460-466.
4. Al-Hajj M, Becker MW, Wicha M, Weissman I, Clarke MF (2004) Therapeutic implications of cancer stem cells. Curr Opin Genet Dev 14: 43-47.
5. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100: 3983-3988.
6. Albino D, Longoni N, Curti L, Mello-Grand M, Pinton S, Civenni G, Thalmann G, D?Ambrosio G, Sarti M, Sessa F, Chiorino G, Catapano CV, Carbone GM (2012) ESE3/EHF controls epithelial cell differentiation and its loss leads to prostate tumors with mesenchymal and stem-like features. Cancer Res 72: 2889-2900.
7. Balanis N, Wendt MK, Schiemann BJ, Wang Z, Schiemann WP, Carlin CR (2013) Epithelial to mesenchymal transition promotes breast cancer progression via a fibronectin-dependent STAT3 signaling pathway. J Biol Chem 288: 1795 4-17967.
8. Baum B, Settleman J, Quinlan MP (2008) Transitions between epithelial and mesenchymal states in development and disease. Semin Cell Dev Biol 19: 294-308.
9. Blick T, Hugo H, Wid odo E, Waltham M, Pinto C, Mani SA, Weinberg RA, Neve RM, Lenburg ME, Thompson EW (2010) Epithelial mesenchymal transition traits in human breast cancer cell lines parallel the CD44(hi/) CD24(lo/-) stem cell phenotype in h uman breast cancer. J Mammary Gland Biol Neoplasia 15: 235-252.
10. Celia-Terrassa T, Meca-Cortes O, Mateo F, De Paz AM, Rubio N, Arnal-Estape A, Ell BJ, Bermudo R, Diaz A, Guerra-Rebollo M, Lozano JJ, Estaras C, Ulloa C, Alvarez-Simon D, Mila J, Vilella R, Paciucci R, Martinez-Balbas M, De Herreros AG, Gomis RR, Kang Y, Blanco J, Fernandez PL, Thomson TM (2012) Epithelial-mesen chymal transition can suppress major attributes of human epithelial tumor-initiating cells. J Clin Invest 122: 1849-1868.
11. Chang CC, Hsu WH, Wang CC, Chou CH, Kuo MY, Lin BR, Chen ST, Tai SK, Kuo ML, Yang MH (2013) Connective tissue growth factor activates pluripotency genes and mesenchymal-epithelial transition in head and neck cancer cells. Cancer Res 73: 4147-4157.
12. Chang CJ, Chao CH, Xia W, Y ang JY, Xiong Y, Li CW, Yu WH, Rehman SK, Hsu JL, Lee HH, Liu M, Chen CT, Yu D, Hung MC (2011) p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs. Nat Cell B iol 13: 317-323.
13. Chao YL, Shepard CR, Wells A (2010) Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition. Mol Cancer 9: 179.
14. Chen SC, Kung ML, Hu TH, Chen HY, Wu JC, Kuo HM, Tsai HE, Lin YW, Wen ZH, Liu JK, Yeh MH, Tai MH (2012) Hepatoma-derived growth factor regulates breast cancer cell invasion by modulating epithelial-mesenchymal transition. J Pathol 228: 158-169.
15. Chiou SH, Wang ML, Chou YT, Chen CJ, Hong CF, Hsieh WJ, Chang HT, Chen YS, Lin TW, Hsu HS, Wu CW (2010) Coexpression of Oct4 and Na nog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation. Cancer Res 70: 10433-10444.
16. Creighton CJ, Li X, Landis M, Dixon JM, Neumeister VM, Sjolund A, Rimm DL, Wong H, Rodriguez A, Herschkowitz JI, Fan C, Zhang X, He X, Pavlick A, Gutierrez MC, Renshaw L, Larionov AA, Faratian D, Hilsenbeck SG, Perou CM, Lewis MT , Rosen JM, Chang JC (2009) Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features. Proc Natl Acad Sci USA 106: 13820-13825.
17. Rizwani W Pillai S Kinkade R Kovacs M Rastogi S Banerjee S Carless M Kim E Coppola D Haura E Chellappan S 2009 Nicotine induces cell proliferation, invasion and epithelial-mesenchymal transition in a variety of human cancer cell lines Int J Cancer 124 36-45.
18. Davies JA (1996) Mesenchyme to epithelium transition during development of the mammalian kidney tubule. Acta Anat (Basel) 156: 187-201.
19. Devarajan E, Song YH, Krishnappa S, Alt E (2012) Epithelial-mesenchymal transition in breast cancer lines is mediated through PDGF-D released by tissue-resident stem cells. Int J Cancer 131: 1023-1031.
20. Docherty NG, O?Sullivan OE, Healy DA, Murphy M, O?Neill AJ, Fitzpatrick JM, Watson RW (2006) TGF-beta1-induced EMT can occur independently of its proapoptotic effects and is aided by EGF receptor activation. Am J P hysiol Renal Physiol 290: F1202-F1212.
21. Fang X, Cai Y, Liu J, Wang Z, Wu Q, Zhang Z, Yang CJ, Yuan L, Ouyang G (2011) Twist2 contributes to breast cancer progression by promoting an epithelial-mesenchymal transition and cancer stem-like cell self-renewal. Oncogene 30: 4707-4720.
22. Fendrich V, Maschuw K, Waldmann J, Buchholz M, Rehm J, Gress TM, Bartsch DK, Konig A (2012) Epithelial-mesenchymal transition is a critical step in tumorgenesis of pancreatic neuroendocrine tumors. Cancers (Basel) 4: 281-294.
23. Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, Jacquem ier J, Viens P, Kleer CG, Liu S, Schott A, Hayes D, Birnbaum D, Wicha MS, Dontu G (2007) ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem C ell 1: 555-567.
24. Han X, Fang X, Lou X, Hua D, Ding W, Foltz G, Hood L, Yuan Y, Lin B (2012) Silencing SOX2 induced mesenchymal-epithelial transition and its expression predicts liver and lymph node metastasis of CRC patients. PLoS One 7: E41335.
25. Iorns E, Drews-Elger K, Ward TM, Dean S, Clarke J, Berry D, El AD, Lippman M (2012) A new mouse model for the study of human breast cance r metastasis. PLoS One 7: E47995.
26. Kalluri R, Weinberg RA (2009) The basics of epithelial-mesenchymal transition. J Clin Invest 119: 1420-1428.
27. Kim J, Jeong H, Lee Y, Kim C, Kim H, Kim A (2013) HRG-beta1-driven ErbB3 signaling induces epithelial-mesenchymal transition in breast cancer cells. BMC Cancer 13: 383.
28. Kim SJ, Yang KM, Jung Y, Lee JM, Kim W, Cho JK, Jeong J (2013) Loss of TBK1 induces epithelial-mesenchymal transition in the breast cancer cells by ERalpha downregulation. Cancer Res 73(22): 6679-6689.
29. Kong D, Banerjee S, Ahmad A, Li Y, Wang Z, Sethi S, Sarkar FH (2010) Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cells. PLoS One 5: E12445.
30. Kutner RH, Zhang XY, Reiser J (2009) Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors. Nat Protoc 4: 495-505.
31. Leontovich AA, Zhang S, Quatraro C, Iankov I, Veroux PF, Gambino MW, Degnim A, McCubrey J, Ingle J, Galanis E, D?Assoro AB (2012) Raf-1 oncogenic signaling is linked to activation of mesenchymal to epithelial transition pathway in metastatic breast cancer cells. Int J Oncol 40: 1858-1864.
32. Li X, Lewis MT, Huang J, Gutierrez C, Osborne CK, Wu MF, Hilsenbeck SG, Pavlick A, Zhang X, Chamness GC, Wong H, Rosen J, Chang JC (2008) Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J Natl Cancer Inst 100: 672-679.
33. Liu M, Casimiro MC, Wang C, Shirley LA, Jiao X, Katiyar S, Ju X, Li Z, Yu Z, Zhou J, Johnson M, Fortina P, Hyslop T, Windle JJ, Pestell RG (2009) p21CIP1 attenuates Ras-and c-Myc-dependent breast tumor epithelial mesenchymal transition and cancer stem cell-like gene expression in vivo. Proc Natl Acad Sci USA 106: 19035-19039.
34. Liu Y, El-Naggar S, Darling DS, Higashi Y, Dean DC (2008) Zeb1 links epithelial-mesenchymal transition and cellular senescence. Development 135: 579-588.
35. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell LL, Polyak K, Brisken C, Yang J, Weinberg RA (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133: 704-715.
36. Meng X, Wang X, Wang Y (2009) More than 45% of A549 and H446 cells are cancer initiating cells: Evidence from cloning and tumorigenic analyses. Oncol Rep 21: 995-1000.
37. Miao Z, Luker KE, Summers BC, Berahovich R, Bhojani MS, Rehemtulla A, Kleer CG, Essner JJ, Nasevicius A, Luker GD, Howard MC, Schall TJ (2007) CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature. Proc Natl Acad Sci USA 104: 15735-15740.
38. Minn AJ Gupta GP Si egel PM Bos PD Shu W Giri DD Viale A Olshen AB Gerald WL Massague J 2005 Genes that mediate breast cancer metastasis to lung Nature 436 518-524.
39. Morel AP, Lievre M, Th omas C, Hinkal G, Ansieau S, Puisieux A (2008) Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One 3: E2888.
40. Nakaya Y, Kuroda S, Katagiri YT, Kaibuchi K, Takahashi Y (2004) Mesenchymal-epithelial transition during somitic segmentation is regulated by differential roles of Cdc42 and Rac1. Dev Cell 7: 425-438.
41. Nguyen PT, Tsunematsu T, Yanagisawa S, Kudo Y, Miyauchi M, Kamata N, Takata T (2013) The FGFR1 inhibitor PD173074 induces mesenchymalepithelial transition through the transcription factor AP-1. Br J Cancer 10 9: 2248-2258.
42. Oliveras-Ferraros C, Corominas-Faja B, Cufi S, Vazquez-Martin A, Martin-Castillo B, Iglesias JM, Lopez-Bonet E, Martin AG, Menendez JA (2012) Epithelial-to-mesenchymal transition (EMT) confers primary resi stance to trastuzumab (Herceptin). Cell Cycle 11: 4020-4032.
43. Park SM, Gaur AB, Lengyel E, Peter ME (2008) The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin re pressors ZEB1 and ZEB2. Genes Dev 22: 894-907.
44. Phillips TM, McBride WH, Pajonk F (2006) The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation. J Natl Cancer Inst 98: 1777-1785.
45. Polyak K, Weinberg RA (2009) Transitions between epithelial and mesenchymal states: Acquisition of malignant and stem cell traits. Nat Rev Cancer 9: 265-273.
46. Ponti D, Costa A, Zaffaroni N, Pratesi G, Petrangolini G, Coradini D, Pilotti S, Pierotti MA, Daidone MG (2005) Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res 65: 5506-5511.
47. Prat A, Parker JS, Karginova O, Fan C, Livasy C, Herschkowitz JI, He X, Perou CM (2010) Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer . Breast Cancer Res 12: R68.
48. Price JE, Polyzos A, Zhang RD, Daniels LM (1990) Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. Cancer Res 50: 717-721.
49. Rosen JM, Jordan CT (2009) The increasing complexity of the cancer stem cell paradigm. Science 324: 1670-1673.
50. St Croix B, Kerbel RS (1997) Cell adhesion and drug resistance in cancer. Curr Opin Oncol 9: 549-556.
51. Sullivan NJ, Sasser AK, Axel AE, Vesuna F, Raman V, Ramirez N, Oberyszyn TM, Hall BM (2009) Interleukin-6 induces an epithelialmesenchymal transition phenot ype in human breast cancer cells. Oncogene 28: 2940-2947.
52. Takebe N, Warren RQ, Ivy SP (2011) Breast cancer growth and metastasis: Interplay between cancer stem cells, embryonic signaling pathways and epithelial-to-mesenchymal transition. Breast Cancer Res 13: 211.
53. Thiery JP, Acloque H, Huang RY, Nieto MA (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139: 871-890.
54. Tsai JH, Donaher JL, Murphy DA, Chau S, Yang J (2012) Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. Cancer Cell 22: 725-736.
55. Xu J, Lamouille S, Derynck R (2009) TGF-beta-induced epithelial to mesenchymal transition. Cell Res 19: 156-172.
56. Yang J, Weinberg RA (2008) Epithelial-mesenchymal transition: At the crossroads of development and tumor metastasis. Dev Cell 14: 818-829.
57. Zhang J, Liang Q, Lei Y, Yao M, Li L, Gao X, Feng J, Zhang Y, Gao H, Liu DX, Lu J, Huang B (2012) SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression. Cancer Res 72: 4597-4608.
58. Zheng X, Shen G , Yang X, Liu W (2007) Most C6 cells are cancer stem cells: Evidence from clonal and population analyses. Cancer Res 67: 3691-3697.